A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
Harbin Medical University is a provincial co-constructed university, a high-level university in Heilongjiang Province and a university with advantageous specialty disciplines, a Chinese-led unit of the Sino-Russian Medical University Alliance, a national science basic science research and teaching talent training base, and the Ministry of Education’s first batch of seven-year advanced institutions Medical education institutions.
Harbin, China Clinical Trial Location
Harbin Medical University
157 Baojian Rd, Nangang,
Harbin, Heilongjiang, Chinaa